Clinical Trials Directory

Trials / Completed

CompletedNCT06529354

24-Week Water Aerobics Program for Adults and Older Adults at Different Intensity Levels

The Role of Exercise Intensity in Water Aerobics: Improving Health Markers in Adults and Older Adults Over 24 Weeks

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University of Beira Interior · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This goal of this clinical trial is to verify the best way to do water aerobics with adults and older adults. It wants to answer these questions: * Is high-intensity water aerobics better than water aerobics performed at moderate intensity? * Does a 24-week water aerobics program improve muscle strength, body weight, fat mass, triglycerides, cholesterol, blood pressure, and quality of life for adults and older adults? Participants must: * Do water aerobics at high or moderate intensity, twice a week for 45 minutes per class, for 24 weeks. * Be assessed before starting the water aerobics program and after it ends to see if there are gains in muscle strength, body weight, fat mass, triglycerides, cholesterol, blood pressure, and quality of life. It was believed that all variables would get better after doing water aerobics, no matter the intensity. It was also expected that doing higher-intensity water aerobics would lead to larger gains in all measurements compared to moderate-intensity.

Conditions

Interventions

TypeNameDescription
BEHAVIORALModerate-intensity GroupIn water aerobics sessions, the exercises are performed at a moderate intensity, between 60% and 70% of the participant's maximum heart rate predicted by their age.
BEHAVIORALHigh-intensity GroupIn water aerobics sessions, the exercises are performed at a high intensity, between 80% and 90% of the participant's maximum heart rate predicted by their age.

Timeline

Start date
2023-01-30
Primary completion
2023-07-21
Completion
2023-07-28
First posted
2024-07-31
Last updated
2024-07-31

Locations

1 site across 1 country: Portugal

Source: ClinicalTrials.gov record NCT06529354. Inclusion in this directory is not an endorsement.